A syndecan that is predominantly expressed during EMBRYONIC DEVELOPMENT. It may play a role in mediating cellular interactions with the EXTRACELLULAR MATRIX and may modulate the signaling activity of certain INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS.
Syndecan 2 has been studied across 15 research domains including 🔬 Oncology, 🦴 Bone & Joint, 🛡️ Immunity, 🔬 Inflammation, ✨ Skin & Hair. The primary research focus is 🔬 Oncology with 44% of studies addressing this area.
This evidence profile for Syndecan 2 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.